Pharmacological Actions of Cannabinoids
Top Cited Papers
- 1 January 2005
- book chapter
- Published by Springer Nature
- No. 168,p. 1-51
- https://doi.org/10.1007/3-540-26573-2_1
Abstract
Mammalian tissues express at least two types of cannabinoid receptor, CB1 and CB2, both G protein coupled. CB1 receptors are expressed predominantly at nerve terminals where they mediate inhibition of transmitter release. CB2 receptorsKeywords
This publication has 202 references indexed in Scilit:
- Inverse agonism and neutral antagonism at cannabinoid CB1 receptorsLife Sciences, 2004
- Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agentsBrain Research Reviews, 2003
- Endocannabinoid hydrolasesProstaglandins & Other Lipid Mediators, 2002
- Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of MiceBiochemical and Biophysical Research Communications, 2002
- Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” LigandsBiochemical and Biophysical Research Communications, 2001
- Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptorsLife Sciences, 1998
- 2-Arachidonoylglycerol, a Putative Endogenous Cannabinoid Receptor Ligand, Induces Rapid, Transient Elevation of Intracellular Free Ca2+in Neuroblastoma × Glioma Hybrid NG108-15 CellsBiochemical and Biophysical Research Communications, 1996
- Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranesLife Sciences, 1996
- Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainLife Sciences, 1996
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995